Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years of rich experience in this field. He is an alumni of Maulana Azad Medical CollegeDelhi from where he did his MBBS, followed by MD Medicine. He has done his DM Medical Oncology from the prestigious AIIMS New Delhi. He has also completed a course on Adverse Drug Reactions, Drug Interactions and Pharmacovigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise inImmunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care. He is the lead author of the largest real world Indian data on targeted therapy(Cetuximab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Papillomavirus trends in Indian Population etc. He is also the lead founder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumor boards, Master Classes and workshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and HaematologyOncology, Previously he was associated with prestigious organization like Rajiv Gandhi Cancer Institute and ResearchCentre and Maulana Azad Medical College.